
Exelixis, Inc.: shareholders and insiders
Price
$65.83
November 19, 2026Market cap $16.1B
What Ploutos Investor adds for Exelixis
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Aug 12, 2026, from their own Form 4 filings.
Bought on the market
$1.2M
1 person
Sold on the market
$35M
11 people
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan20%
- The rest80%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $32M by 11 people
- 2025: bought $1.2M by 1 person, sold $3.0M by 1 person
- 2026: no buys, sold $32M by 11 people
- Aug 10, 2026Mary C BeckerleDirectorKind10b5-1
- Jun 1, 2026Jack L WyszomierskiDirectorKind10b5-1
- Jun 1, 2026Sue Gail EckhardtDirectorKind10b5-1
- May 27, 2026Stelios PapadopoulosDirectorKind
- May 27, 2026Tomas J. HeymanDirectorKind
- May 27, 2026Sue Gail EckhardtDirectorKind
- May 27, 2026Julie SmithDirectorKind
- May 27, 2026Maria C FreireDirectorKind
- May 27, 2026Mary C BeckerleDirectorKind
- May 27, 2026Bob OliverDirectorKind
- May 27, 2026Jack L WyszomierskiDirectorKind
- May 27, 2026George PosteDirectorKind
- May 26, 2026Dana AftabEVP, Research and DevelopmentKind
- May 20, 2026Patrick J. HaleyEVP, CommercialKind
- May 18, 2026Brenda HeftiSVP and General CounselKind10b5-1
- May 18, 2026Christopher J. SennerEVP and CFOKind
- May 7, 2026George PosteKind
- May 7, 2026Maria C FreireKind
- May 7, 2026Mary C BeckerleKind
- Feb 24, 2026Dana AftabEVP, Research and DevelopmentKind
- Feb 19, 2026Dana AftabEVP, Research and DevelopmentKind
- Feb 18, 2026Jack L WyszomierskiKind10b5-1
- Feb 18, 2026Julie SmithKind
- Feb 18, 2026Julie SmithKind
- Feb 18, 2026Brenda HeftiSVP and General CounselKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Mary C BeckerleDirector | 10b5-1 | 9,812 | $53.66 | $526.5K | Form 4 |
| Jun 1, 2026 | Jack L WyszomierskiDirector | 10b5-1 | 3,925 | $50.55 | $198.4K | Form 4 |
| Jun 1, 2026 | Sue Gail EckhardtDirector | 10b5-1 | 9,812 | $50.14 | $492.0K | Form 4 |
| May 27, 2026 | Stelios PapadopoulosDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | Tomas J. HeymanDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | Sue Gail EckhardtDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | Julie SmithDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | Maria C FreireDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | Mary C BeckerleDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | Bob OliverDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | Jack L WyszomierskiDirector | 8,367 | – | – | Form 4 | |
| May 27, 2026 | George PosteDirector | 8,367 | – | – | Form 4 | |
| May 26, 2026 | Dana AftabEVP, Research and Development | 43.5K | $50.35 | $2.2M | Form 4 | |
| May 20, 2026 | Patrick J. HaleyEVP, Commercial | 32.1K | $49.81 | $1.6M | Form 4 | |
| May 18, 2026 | Brenda HeftiSVP and General Counsel | 10b5-1 | 6,625 | $50.21 | $332.6K | Form 4 |
| May 18, 2026 | Christopher J. SennerEVP and CFO | 34.9K | $50.00 | $1.7M | Form 4 | |
| May 7, 2026 | George Poste | 60.0K | $45.71 | $2.7M | Form 4 | |
| May 7, 2026 | Maria C Freire | 20.6K | $46.00 | $949.2K | Form 4 | |
| May 7, 2026 | Mary C Beckerle | 7,712 | $48.45 | $373.6K | Form 4 | |
| Feb 24, 2026 | Dana AftabEVP, Research and Development | 47.9K | $44.50 | $2.1M | Form 4 | |
| Feb 19, 2026 | Dana AftabEVP, Research and Development | 29.9K | $44.35 | $1.3M | Form 4 | |
| Feb 18, 2026 | Jack L Wyszomierski | 10b5-1 | 99.6K | $44.01 | $4.4M | Form 4 |
| Feb 18, 2026 | Julie Smith | 20.0K | $44.30 | $887.3K | Form 4 | |
| Feb 18, 2026 | Julie Smith | 44.1K | $44.50 | $2.0M | Form 4 | |
| Feb 18, 2026 | Brenda HeftiSVP and General Counsel | 10b5-1 | 18.7K | $44.01 | $821.6K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 28, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by EXEL's officers and directors from 2002 up to November 19, 2025, 24 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 19 more, back to 2002
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class10.2%
- Farallon Capital Management, L.L.C.with 15 more personsShare of class6.00%
- Vanguard Capital ManagementShare of class5.09%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10.2% | 28.50M | Apr 28, 2025 | 13G/A | |
| Farallon Capital Management, L.L.C.with 15 more persons | 6.00% | 14.69M | Nov 9, 20266 filings since Mar 5, 2025 | 13G | |
| Vanguard Capital Management | 5.09% | 13.23M | Apr 29, 2026 | 13G |
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter-4.7%
- D.E. ShawIn the quarter+0.9%
- AQR CapitalIn the quarter-13%
- Bridgewater (Dalio)In the quarter-18%
- Millennium Mgmt (Englander)In the quarter-71%
- Citadel Advisors (Griffin)In the quarter-8.6%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 12.79M | -4.7% | $747M | 1.02% |
| D.E. Shaw | 5.60M | +0.9% | $327M | 0.21% |
| AQR Capital | 9.61M | -13% | $561M | 0.17% |
| Bridgewater (Dalio) | 328.6K | -18% | $19M | 0.08% |
| Millennium Mgmt (Englander) | 354.9K | -71% | $21M | 0.02% |
| Citadel Advisors (Griffin) | 64.8K | -8.6% | $3.8M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 11.2% of its shares outstanding were held short, -3.1% since the report before.
- Shares held short
- 27.31M
- 11.2%
- Since the report before28.18M on Sep 30, 2026
- -3.1%
- 11.3
- 2.41M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 94%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 9.26M
- Nov 15, 2023: Shares held short 9.70M
- Nov 30, 2023: Shares held short 9.81M
- Dec 15, 2023: Shares held short 9.74M
- Dec 29, 2023: Shares held short 8.11M
- Jan 12, 2024: Shares held short 8.56M
- Jan 31, 2024: Shares held short 7.31M
- Feb 15, 2024: Shares held short 8.37M
- Feb 29, 2024: Shares held short 8.85M
- Mar 15, 2024: Shares held short 8.25M
- Mar 28, 2024: Shares held short 6.83M
- Apr 15, 2024: Shares held short 8.62M
- Apr 30, 2024: Shares held short 9.57M
- May 15, 2024: Shares held short 10.71M
- May 31, 2024: Shares held short 10.40M
- Jun 14, 2024: Shares held short 9.94M
- Jun 28, 2024: Shares held short 9.19M
- Jul 15, 2024: Shares held short 9.03M
- Jul 31, 2024: Shares held short 10.16M
- Aug 15, 2024: Shares held short 11.79M
- Aug 30, 2024: Shares held short 12.03M
- Sep 13, 2024: Shares held short 12.69M
- Sep 30, 2024: Shares held short 10.05M
- Oct 15, 2024: Shares held short 9.98M
- Oct 31, 2024: Shares held short 9.12M
- Nov 15, 2024: Shares held short 7.90M
- Nov 29, 2024: Shares held short 8.36M
- Dec 13, 2024: Shares held short 7.33M
- Dec 31, 2024: Shares held short 10.45M
- Jan 15, 2025: Shares held short 14.46M
- Jan 31, 2025: Shares held short 13.09M
- Feb 14, 2025: Shares held short 16.15M
- Feb 28, 2025: Shares held short 13.29M
- Mar 14, 2025: Shares held short 13.18M
- Mar 31, 2025: Shares held short 14.86M
- Apr 15, 2025: Shares held short 18.23M
- Apr 30, 2025: Shares held short 19.18M
- May 15, 2025: Shares held short 18.72M
- May 30, 2025: Shares held short 18.61M
- Jun 13, 2025: Shares held short 20.39M
- Jun 30, 2025: Shares held short 19.38M
- Jul 15, 2025: Shares held short 18.27M
- Jul 31, 2025: Shares held short 17.37M
- Aug 15, 2025: Shares held short 16.90M
- Aug 29, 2025: Shares held short 17.63M
- Sep 15, 2025: Shares held short 17.59M
- Sep 30, 2025: Shares held short 17.75M
- Oct 15, 2025: Shares held short 20.88M
- Oct 31, 2025: Shares held short 19.79M
- Nov 14, 2025: Shares held short 20.15M
- Nov 28, 2025: Shares held short 21.36M
- Dec 15, 2025: Shares held short 22.83M
- Dec 31, 2025: Shares held short 24.70M
- Jan 15, 2026: Shares held short 25.77M
- Jan 30, 2026: Shares held short 27.88M
- Feb 13, 2026: Shares held short 28.81M
- Feb 27, 2026: Shares held short 26.32M
- Mar 13, 2026: Shares held short 26.35M
- Mar 31, 2026: Shares held short 27.26M
- Apr 15, 2026: Shares held short 28.31M
- Apr 30, 2026: Shares held short 30.01M
- May 15, 2026: Shares held short 30.28M
- May 29, 2026: Shares held short 29.71M
- Jun 15, 2026: Shares held short 30.64M
- Jun 30, 2026: Shares held short 28.54M
- Jul 15, 2026: Shares held short 30.91M
- Jul 31, 2026: Shares held short 28.75M
- Aug 14, 2026: Shares held short 28.03M
- Aug 31, 2026: Shares held short 28.66M
- Sep 15, 2026: Shares held short 26.40M
- Sep 30, 2026: Shares held short 28.18M
- Oct 15, 2026: Shares held short 27.31M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading50.3% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 50.3% of the shares in the reported trades were short sales, against 57.5% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 50.3%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 57.5%
- Change
- -7.2 pts
- Short sales a dayon average, of 1.08M shares
- 543.3K
- More than atof 3,666 US-listed companies, same days
- 49%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 55.9%
- Oct 14, 2026: Short sales 47.3%
- Oct 15, 2026: Short sales 59.7%
- Oct 16, 2026: Short sales 63.9%
- Oct 19, 2026: Short sales 48.4%
- Oct 20, 2026: Short sales 51.4%
- Oct 21, 2026: Short sales 50.8%
- Oct 22, 2026: Short sales 50.3%
- Oct 23, 2026: Short sales 66.4%
- Oct 26, 2026: Short sales 63.1%
- Oct 27, 2026: Short sales 55.2%
- Oct 28, 2026: Short sales 61.5%
- Oct 29, 2026: Short sales 67.9%
- Oct 30, 2026: Short sales 57.5%
- Nov 2, 2026: Short sales 30.5%
- Nov 3, 2026: Short sales 51.2%
- Nov 4, 2026: Short sales 61.8%
- Nov 5, 2026: Short sales 50.5%
- Nov 6, 2026: Short sales 39.5%
- Nov 9, 2026: Short sales 42.2%
- Nov 10, 2026: Short sales 60.1%
- Nov 11, 2026: Short sales 63.1%
- Nov 12, 2026: Short sales 58.8%
- Nov 13, 2026: Short sales 61.6%
- Nov 16, 2026: Short sales 46.5%
- Nov 17, 2026: Short sales 52.1%
- Nov 18, 2026: Short sales 58.1%
- Nov 19, 2026: Short sales 68.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Caligan Partners LPDirector,OtherDirectly–
- David Edward JohnsonDirectorDirectly–
- Stelios PapadopoulosDirectorDirectly1.20M
- Christopher J. SennerEVP and CFODirectly952.3K
- Jeffrey HessekielEVP & General CounselDirectly693.4K
- Dana AftabEVP, Research and DevelopmentDirectly594.7K
- Amy C. PetersonEVP Prod Dev & Med Aff & CMODirectly465.4K
- Patrick J. HaleyEVP, CommercialDirectly357.6K
- Jack L WyszomierskiDirectorDirectly284.4K
- George PosteDirectorDirectly127.2K
- Maria C FreireDirectorDirectly109.2K
- Brenda HeftiSVP and General CounselDirectly106.8K
- Tomas J. HeymanDirectorDirectly50.6K
- Alan M GarberDirectorDirectly35.7K
- Bob OliverDirectorDirectly29.5K
- Julie SmithDirectorDirectly29.0K
- Mary C BeckerleDirectorDirectly16.1K
- Sue Gail EckhardtDirectorDirectly16.1K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Caligan Partners LPDirector,Other | – | 1.55M | Nov 25, 2025 | Form 4 |
| David Edward JohnsonDirector | – | 1.53M | May 30, 2024 | Form 4 |
| Stelios PapadopoulosDirector | 1.20M | – | May 27, 2026 | Form 4 |
| Christopher J. SennerEVP and CFO | 952.3K | – | May 18, 2026 | Form 4 |
| Jeffrey HessekielEVP & General Counsel | 693.4K | – | May 15, 2025 | Form 4 |
| Dana AftabEVP, Research and Development | 594.7K | – | May 26, 2026 | Form 4 |
| Amy C. PetersonEVP Prod Dev & Med Aff & CMO | 465.4K | – | May 16, 2025 | Form 4 |
| Patrick J. HaleyEVP, Commercial | 357.6K | – | May 20, 2026 | Form 4 |
| Jack L WyszomierskiDirector | 284.4K | – | Jun 1, 2026 | Form 4 |
| George PosteDirector | 127.2K | – | May 27, 2026 | Form 4 |
| Maria C FreireDirector | 109.2K | – | May 27, 2026 | Form 4 |
| Brenda HeftiSVP and General Counsel | 106.8K | – | May 18, 2026 | Form 4 |
| Tomas J. HeymanDirector | 50.6K | – | May 27, 2026 | Form 4 |
| Alan M GarberDirector | 35.7K | – | Mar 21, 2024 | Form 4 |
| Bob OliverDirector | 29.5K | – | May 27, 2026 | Form 4 |
| Julie SmithDirector | 29.0K | – | May 27, 2026 | Form 4 |
| Mary C BeckerleDirector | 16.1K | – | Aug 10, 2026 | Form 4 |
| Sue Gail EckhardtDirector | 16.1K | – | Jun 1, 2026 | Form 4 |
A lower bound: it counts only the 18 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XMHQInvesco S&P MidCap Quality ETFWeight in the fund2.70%
- IBBiShares Biotechnology ETFWeight in the fund1.03%
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund0.96%
- CALFPacer US Small Cap Cash Cows 100 ETFWeight in the fund0.89%
- IJKiShares S&P Mid-Cap 400 Growth ETFWeight in the fund0.72%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.69%
- FMDEFidelity Enhanced Mid Cap Core ETFWeight in the fund0.60%
- SPMDState Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETFWeight in the fund0.38%
- IJHiShares Core S&P Mid-Cap ETFWeight in the fund0.38%
- MDYState Street SPDR S&P MidCap 400SM ETF TrustWeight in the fund0.38%
44 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 622
- Q4 2025: Managers 686
- Q1 2026: Managers 704
- Q2 2026: Managers 757
Institutional investors by quarter
The fund managers holding EXEL, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 757 managers held 260M shares, worth $14.1B. During the quarter 130 opened a position, 77 closed one, 254 added and 277 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter-5.6%
- Farallon Capital ManagementIn the quarter+2.7%
- Renaissance TechnologiesIn the quarter-2.2%
- Vanguard Portfolio ManagementIn the quarter-0.3%
- AQR CapitalIn the quarter-16%
- Vanguard Capital ManagementIn the quarter-2.7%
- State StreetIn the quarter-3.2%
- Fuller & Thaler Asset ManagementIn the quarter+4.5%
- LSV Asset ManagementIn the quarter+5.2%
- Geode Capital ManagementIn the quarter-1.9%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 29.08M | -5.6% | $1.6B |
| Farallon Capital Management | 13.47M | +2.7% | $733M |
| Renaissance Technologies | 13.43M | -2.2% | $731M |
| Vanguard Portfolio Management | 12.04M | -0.3% | $655M |
| AQR Capital | 11.02M | -16% | $599M |
| Vanguard Capital Management | 10.95M | -2.7% | $596M |
| State Street | 9.97M | -3.2% | $542M |
| Fuller & Thaler Asset Management | 8.93M | +4.5% | $486M |
| LSV Asset Management | 8.15M | +5.2% | $443M |
| Geode Capital Management | 7.65M | -1.9% | $416M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Exelixis's filings show?
Who buys and sells is one part of Exelixis's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have EXEL's insiders bought or sold?
From May 28, 2026 to Aug 12, 2026 Exelixis's insiders bought 0 and sold $3.4M of shares on the market. 36% of the sales were under set 10b5-1 plans.
Which well-known managers hold EXEL?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $747M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.